Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

VYONDYS 53

GOLODIRSEN

Standard Dose
100MG/2ML (50MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VYONDYS 53 is listed in Drugs@FDA under application 211970 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GOLODIRSEN Form and strength SOLUTION;INTRAVENOUS - 100MG/2ML (50MG/ML) Sponsor SAREPTA THERAPS INC Submission history Latest submission status date: 2024-06-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview VYONDYS 53 is listed in Drugs@FDA under application 211970 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GOLODIRSEN Form and strength SOLUTION;INTRAVENOUS - 100MG/2ML (50MG/ML) Sponsor SAREPTA THERAPS INC Submission history Latest submission status date: 2024-06-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.